Medtronic announces FDA approval of minimally invasive device to treat hypertension

Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology Medtronic plc (NYSE: MDT), a ...

November 20, 2023 | Monday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...

November 17, 2023 | Friday | News
Vertex and CRISPR Therapeutics Granted Historic Approval for CASGEVY™, the World's First CRISPR/Cas9 Gene-Edited Therapy, by UK MHRA to Combat Sickle Cell Disease and Beta Thalassemia

 - First regulatory authorization of a CRISPR-based gene-editing therapy in the world – - CASGEVY is indicated for the treatment of sickle cell...

November 17, 2023 | Friday | News
T-Therapeutics Secures £48M in Series A for Advancing Next-Gen TCR Therapeutics in Cancer Treatment Transformation.

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofin...

November 16, 2023 | Thursday | News
QIAGEN Introduces TissueLyser III and RNeasy PowerMax Soil Pro Kit for Enhanced Sample Processing and RNA Isolation

QIAGEN announced the expansion of its sample technologies portfolio with the introduction of two new products aimed at supporting researchers in managing d...

November 16, 2023 | Thursday | News
£14.5 Million Funding Boost for Neurodegenerative Research Projects in the UK

Seven major research projects to receive more than £14 million to develop new tests, treatments and devices for neurodegenerative diseases includin...

November 14, 2023 | Tuesday | News
Novo Nordisk Executive Vice President, Henrik Wulff, Affirms Commitment with Significant Investment in New API Facility for Global Capacity Expansion

Novo Nordisk  announced plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg...

November 13, 2023 | Monday | News
Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Uli...

November 13, 2023 | Monday | News
Sandoz Opens Antibiotic Plant in Austria, Biosimilar Center in Germany

Investment of EUR 175 million reaffirms Sandoz commitment to long-term leadership in off-patent medicines New penicillin production process will signifi...

November 13, 2023 | Monday | News
STADA, Alvotech Get Positive CHMP Nod for Europe's First Ustekinumab Biosimilar to Stelara

Positive CHMP opinion for Uzpruvo biosimilar is based on comprehensive package comprising analytical, non-clinical and clinical similarity data, includin...

November 13, 2023 | Monday | News
MoonLake Immunotherapeutics Reveals Breakthrough Phase 2 Results for Nanobody® Sonelokimab in Psoriatic Arthritis

First placebo-controlled randomized trial in active psoriatic arthritis (PsA) using a Nanobody® to report positive topline results in support of pote...

November 06, 2023 | Monday | News
Pfizer Advances GLP-1 Receptor Agonist PF-06954522 to Phase 1 Trial with Sosei Heptares Collaboration

Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) has been notified by Pfizer that it has entered a new oral s...

November 06, 2023 | Monday | News
EU Grants Approval to Novavax's Enhanced COVID-19 Vaccine

Novavax's updated COVID-19 vaccine is the only updated protein-based non-mRNA COVID-19 vaccine available in the European Union for individuals aged 12 an...

November 01, 2023 | Wednesday | News
Valneva Submits Chikungunya Vaccine for Accelerated EMA Assessment

VLA1553 is currently the first and only chikungunya vaccine candidate worldwide for which regulatory review processes are underway. A Biologic License Appl...

October 26, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close